Litcius/Paper detail

An enolase inhibitor for the targeted treatment of ENO1-deleted cancers

Yu-Hsi Lin, Nikunj Satani, Naima Hammoudi, Victoria C. Yan, Yasaman Barekatain, Sunada Khadka, Jeffrey J. Ackroyd, Dimitra K. Georgiou, Cong-Dat Pham, Kenisha Arthur, David S. Maxwell, Zhenghong Peng, Paul G. Leonard, Barbara Czakó, Federica Pisaneschi, Pijus K. Mandal, Yuting Sun, Rafał Zieliński, Susana Castro-Pando, Xiaobo Wang, Theresa Tran, Quanyu Xu, Qi Wu, Yongying Jiang, Zhijun Kang, John M. Asara, Waldemar Priebe, William G. Bornmann, Joseph R. Marszalek, Ronald A. DePinho, Florian L. Müller

2020Nature Metabolism103 citationsDOIOpen Access PDF

Topics & Concepts

EnolaseCancer researchGlycolysisIn vivoBiologyGliomaGene isoformCancerCollateral damageEnzymeCancer cellBiochemistryImmunologyImmunohistochemistryGeneGeneticsCriminologySociologyATP Synthase and ATPases ResearchCancer, Hypoxia, and MetabolismS100 Proteins and Annexins
An enolase inhibitor for the targeted treatment of ENO1-deleted cancers | Litcius